Interpace Biosciences, Inc.
IDXG
$1.25
$0.00280.23%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.28M | 2.06M | 468.00K | 890.00K | -614.00K |
| Total Depreciation and Amortization | 189.00K | 188.00K | 160.00K | 647.00K | 352.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 14.00K |
| Total Other Non-Cash Items | 494.00K | 7.00K | 122.00K | 434.00K | 436.00K |
| Change in Net Operating Assets | 153.00K | -853.00K | -808.00K | -831.00K | 917.00K |
| Cash from Operations | 2.12M | 1.40M | -58.00K | 1.14M | 1.11M |
| Capital Expenditure | -522.00K | -197.00K | -28.00K | -142.00K | -152.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 500.00K |
| Cash from Investing | -522.00K | -197.00K | -28.00K | -142.00K | 348.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.50M | -2.00M | -600.00K | 0.00 | -1.50M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -32.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -2.50M | -- |
| Cash from Financing | -1.50M | -2.00M | -600.00K | -2.53M | -1.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.00K | -793.00K | -686.00K | -1.53M | -47.00K |
